Leukocyte Imbalances in Mucopolysaccharidoses Patients
Authors:
- Nuno LopesNLNuno Lopes
- Maria L. MaiaMMMaria L. Maia
- Cátia S. PereiraCPCátia S. Pereira
- Inês Mondragão-RodriguesIMInês Mondragão-Rodrigues
- Esmeralda MartinsEMEsmeralda Martins
- Rosa RibeiroRRRosa Ribeiro
- Ana GasparAGAna Gaspar
- Patrício AguiarPAPatrício Aguiar
- Paula GarciaPGPaula Garcia
- Maria Teresa CardosoMCMaria Teresa Cardoso
- Esmeralda RodriguesEREsmeralda Rodrigues
- Elisa Leão-TelesELElisa Leão-Teles
Open Access
- 13 June 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (6) , 1699
Abstract
Mucopolysaccharidoses (MPSs) are rare inherited lysosomal storage diseases (LSDs) caused by deficient activity in one of the enzymes responsible for glycosaminoglycans lysosomal degradation. MPS II is caused by pathogenic mutations in the IDS gene, leading to deficient activity of the enzyme iduronate-2-sulfatase, which causes dermatan and heparan sulfate storage in the lysosomes. In MPS VI, there is dermatan sulfate lysosomal accumulation due to pathogenic mutations in the ARSB gene, leading to arylsulfatase B deficiency. Alterations in the immune system of MPS mouse models have already been described, but data concerning MPSs patients is still scarce. Herein, we study different leukocyte populations in MPS II and VI disease patients. MPS VI, but not MPS II patients, have a decrease percentage of natural killer (NK) cells and monocytes when compared with controls. No alterations were identified in the percentage of T, invariant NKT, and B cells in both groups of MPS disease patients. However, we discovered alterations in the naïve versus memory status of both helper and cytotoxic T cells in MPS VI disease patients compared to control group. Indeed, MPS VI disease patients have a higher frequency of naïve T cells and, consequently, lower memory T cell frequency than control subjects. Altogether, these results reveal MPS VI disease-specific alterations in some leukocyte populations, suggesting that the type of substrate accumulated and/or enzyme deficiency in the lysosome may have a particular effect on the normal cellular composition of the immune system.Keywords
All Related Versions
Funding Information
- national funds (UIDB/04293/2020)
This publication has 54 references indexed in Scilit:
- Natural killer cell deficiencyJournal of Allergy and Clinical Immunology, 2013
- Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis I (MPS I)Journal of Inherited Metabolic Disease, 2012
- Therapy for the mucopolysaccharidosesRheumatology, 2011
- Glycosaminoglycan Storage Disorders: A ReviewBiochemistry Research International, 2011
- Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatmentGenetics and Molecular Biology, 2010
- Mucopolysaccharidosis VIOrphanet Journal of Rare Diseases, 2010
- Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VIPathoGenetics, 2009
- Leukocyte perturbation associated with Fabry diseaseJournal of Inherited Metabolic Disease, 2009
- The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cellsJournal of Experimental Medicine, 2007
- Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseasesJournal of Experimental Medicine, 2006